Targeted strategies directed at the molecular defect: Toward precision medicine for select primary immunodeficiency disorders.

ABSTRACT: Primary immunodeficiency disorders (PIDs) represent a range of genetically determined diseases that typically have increased susceptibility to infections and in many cases also have evidence of immune dysregulation that often presents as autoimmunity. Most recently, the concept of gain-of-function mutations associated with PIDs has become well recognized and adds a new dimension to the understanding of this group of disorders, moving beyond the more commonly seen loss-of-function mutations. The rapidly expanding genetic defects that have been identified in patients with previously uncharacterized PIDs has opened up the potential for targeted therapy directed at the specific disease-causing abnormality. This has been driven by linking PID-specific genetic defects to the associated unique ab

SUBMITTER: Notarangelo LD 

PROVIDER: S-EPMC5369241 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature